<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "afatinib tab">
<dose><value>20</value>
<value>30</value>
<value>40</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>20 mg</value>
<value>30 mg</value>
<value>40 mg</value>
</strength>
<frequency><value>DAILY</value>
</frequency>
<instruction></instruction>
<volume></volume>
<units><value>mg</value>
</units>
<Population><value>Afatinib. Advanced or Metastatic Non-Small Cell Lung Cancer.</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Continuous dosing; 1 cycle = 28 days.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=5021</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=7141</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=7161</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>